KIF9 anticorps (N-Term)
Aperçu rapide pour KIF9 anticorps (N-Term) (ABIN634155)
Antigène
Voir toutes KIF9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- KIF9 antibody was raised against the n terminal of KIF9
-
Purification
- Affinity purified
-
Immunogène
- KIF9 antibody was raised using the N terminal of KIF9 corresponding to a region with amino acids MGTRKKVHAFVRVKPTDDFAHEMIRYGDDKRSIDIHLKKDIRRGVVNNQQ
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
KIF9 Blocking Peptide, (ABIN5614355), is also available for use as a blocking control in assays to test for specificity of this KIF9 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of KIF9 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- KIF9 (Kinesin Family Member 9 (KIF9))
-
Autre désignation
- KIF9
-
Sujet
- KIF9 acts as a regulator of podosomes and of podosomal matrix degradation in primary human macrophages.
-
Poids moléculaire
- 90 kDa (MW of target protein)
Antigène
-